LSE - Delayed Quote USD

Enovis Corporation (0I1B.L)

34.10

+2.26

+(7.09%)

As of April 30 at 5:40:02 PM GMT+1. Market Open.

3 Dawdling Stocks in Hot Water

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

StockStory 5 hours ago

ENOV

CRI
Enovis Corporation (ENOV): Among Billionaire Mason Hawkins’ Small-Cap Stocks with Huge Upside Potential

We recently published a list of Billionaire Mason Hawkins’ 10 Small-Cap Stocks with Huge Upside Potential. In this article, we are going to take a look at where Enovis Corporation (NYSE:ENOV) stands against other billionaire Mason Hawkins’ small-cap stocks with huge upside potential. Mason Hawkins’s Value Investment Strategy Mason Hawkins is a prominent American investor, […]

Insider Monkey 2 days ago

ENOV
1 Unprofitable Stock with Competitive Advantages and 2 to Question

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.

StockStory 2 days ago

FSLY

ENOV
Are Options Traders Betting on a Big Move in Enovis (ENOV) Stock?

Investors need to pay close attention to Enovis (ENOV) stock based on the movements in the options market lately.

Zacks 9 days ago

ENOV
Reasons to Sell ENOV and 1 Stock to Buy Instead

What a brutal six months it’s been for Enovis. The stock has dropped 22.5% and now trades at $31.96, rattling many shareholders. This might have investors contemplating their next move.

StockStory 14 days ago

ENOV
Enovis to Host First Quarter 2025 Results Conference Call on May 8th

Wilimington, DE, April 17, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2025 financial results on Thursday, May 8th, 2025 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call, as well as a webcast, can be accessed from the "Investors" section of Enovis' website

GlobeNewswire 14 days ago

ENOV
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Think Twice About

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

StockStory 20 days ago

ENOV

BBCP

DECK
Spotting Winners: STAAR Surgical (NASDAQ:STAA) And Medical Devices & Supplies - Specialty Stocks In Q4

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including STAAR Surgical (NASDAQ:STAA) and its peers.

StockStory 21 days ago

STAA

INSP

ITGR
Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest

Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 medical devices & supplies - specialty earnings season.

StockStory 23 days ago

ITGR

HAE

INSP
Enovis appoints Damien McDonald as CEO

McDonald, who is set to start as CEO on May 12, is joining a business that has expanded quickly in the orthopedic reconstruction sector.

MedTech Dive 25 days ago

ENOV
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

Damien McDonald appointed CEO, effective as of May 12, 2025Company reiterates guidance for first quarter revenues and aEBITDA WIlmington. DE, April 02, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “The Company”) (NYSE: ENOV), a leader in medical technology innovation, today announced the appointment of Damien McDonald as Chief Executive Officer, effective May 12, 2025. Mr. McDonald will also join the Enovis Board of Directors following the conclusion of the Company’s 2025 Annual Mee

GlobeNewswire 29 days ago

ENOV
2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 11.1%. This drop was worse than the S&P 500’s 4% loss.

StockStory last month

ENOV
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

Alongside an evidence-based portfolio, Enovis will showcase how it’s “Redefining Every Step” with confidence-building education and a partnership that goes beyond the product; attendees invited to exclusive events. Enovis Featured Products at ACFAS 2025 Enovis Foot & Ankle will be featuring these products at ACFAS 2025, March 27-30, in Phoenix, Arizona. WILMINGTON, DE, March 25, 2025 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), a global medical technology innovator, will feature its expanding portf

GlobeNewswire last month

ENOV
3 Stocks Under $50 in the Doghouse

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

StockStory last month

ENOV

WEN

LXFR
Enovis to Participate in Upcoming Investor Conferences

Wilmington, DE, March 05, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Canaccord Genuity Musculoskeletal Conference: Ben Berry, Chief Financial Officer, and Louie Vogt, Group President - Recon, will participate in a fireside chat on Monday, March 10th at 10:00 a.m. Pacific Time.37th Annual Roth Conference: Louie Vogt, Group Presid

GlobeNewswire last month

ENOV
Enovis Full Year 2024 Earnings: EPS Misses Expectations

Enovis ( NYSE:ENOV ) Full Year 2024 Results Key Financial Results Revenue: US$2.11b (up 24% from FY 2023). Net loss...

Simply Wall St. 2 months ago

ENOV
Enovis Corp (ENOV) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook

Enovis Corp (ENOV) reports a robust 23% revenue increase and outlines strategic goals for 2025 amidst market challenges.

GuruFocus.com 2 months ago

ENOV
Q4 2024 Enovis Corp Earnings Call

Q4 2024 Enovis Corp Earnings Call

Thomson Reuters StreetEvents 2 months ago

ENOV
Enovis (ENOV) Q4 Earnings and Revenues Surpass Estimates

Enovis (ENOV) delivered earnings and revenue surprises of 6.52% and 0.84%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

ENOV
Enovis (NYSE:ENOV) Exceeds Q4 Expectations

Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 23.3% year on year to $561 million. On the other hand, the company’s full-year revenue guidance of $2.21 billion at the midpoint came in 0.8% below analysts’ estimates. Its non-GAAP profit of $0.98 per share was 7% above analysts’ consensus estimates.

StockStory 2 months ago

ENOV

Performance Overview

Return	0I1B.L	MSCI WORLD (^990100-USD-STRD)
YTD	--	-0.82%
1-Year	--	+10.71%
3-Year	-38.75%	+31.51%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Enovis Corporation (0I1B.L)

3 Dawdling Stocks in Hot Water

Enovis Corporation (ENOV): Among Billionaire Mason Hawkins’ Small-Cap Stocks with Huge Upside Potential

1 Unprofitable Stock with Competitive Advantages and 2 to Question

Are Options Traders Betting on a Big Move in Enovis (ENOV) Stock?

Reasons to Sell ENOV and 1 Stock to Buy Instead

Enovis to Host First Quarter 2025 Results Conference Call on May 8th

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Think Twice About

Spotting Winners: STAAR Surgical (NASDAQ:STAA) And Medical Devices & Supplies - Specialty Stocks In Q4

Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest

Enovis appoints Damien McDonald as CEO

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

3 Stocks Under $50 in the Doghouse

Enovis to Participate in Upcoming Investor Conferences

Enovis Full Year 2024 Earnings: EPS Misses Expectations

Enovis Corp (ENOV) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook

Q4 2024 Enovis Corp Earnings Call

Enovis (ENOV) Q4 Earnings and Revenues Surpass Estimates

Enovis (NYSE:ENOV) Exceeds Q4 Expectations

Performance Overview